Food and Drug Administration
Anti-Viral Drugs Advisory Committee
March 19, 2002
Briefing Information
NDA 21-245 Picovir™ (pleconaril) for treatment of acute picornaviral upper respiratory infection (common cold) in adults
Disclaimer
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Sponsor - ViroPharma Incorporated pdf